Dr Max Barnish
Research Fellow
M.S.Barnish@exeter.ac.uk
3809
01392 723809
South Cloisters 3.09f
South Cloisters, University of Exeter, St Luke's Campus, Heavitree Road, Exeter, EX1 2LU, UK
Overview
Max is Research Fellow in Health Technology Assessment (Project Manager), working with the Peninsula Technology Assessment Group (PenTAG), one of 11 research units in the UK providing expert advice on the clinical- and cost-effectiveness of new drugs and medical devices to the National Institute of Health and Care Research (NICE) Technology Appraisal committees. PenTAG also supports the work of NICE's Medical Technologies Evaluation Programme and the Singapore Ministry of Health. Max's primary expertise is in clinical effectiveness systematic reviewing, epidemiology, health policy and methods for systematic and realist reviews.
Qualifications
- PhD, Health Sciences (University of East Anglia)
- MSc, Speech and Hearing Sciences (UCL)
- MA, English (Open)
- MA, Linguistics (Cambridge, undergraduate)
Career
- 2018-present, Research Fellow, University of Exeter
- 2017-2018, Postdoctoral Research Associate, University of Exeter
- 2014-2017, Research Assistant, University of Aberdeen
Research group links
Research
Research interests
My research interests are twofold:
a. Social epidemiology and health policy, especially on a global scale.
b. The use of systematic and realist review methods for evidence synthesis
Research projects
Recent commissioned policy projects include:
a. Ivosidenib with azacitidine for untreated IDH1-positive acute myeloid leukaemia.
b. Digital pulmonary rehabilitation technologies for adults with chronic obstructive pulmonary disease.
c. Treatments for renal cell carcinoma.
d. Virtual reality for treating agoraphobia and agoraphobic avoidance: early value assessment.
e. Axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Research networks
- Fellow of the Royal Society for Public Health
- Fellow of the Royal Statistical Society
- Member of HTAi
- Member of Society for Social Medicine & Population Health (2018 ECR Chair)
- Member of departmental Early Career Research Network
Research grants
- 2017 Society for Social Medicine and Population Health
Annual Scientific Meeting ECR Free Place [Lead applicant] - 2010 University of East Anglia
PhD Studentship: Relationships between cognitive status, speech impairment, and communicative participation in people with Parkinson's disease [Lead applicant]
Publications
Journal articles
Barnish M, Tan SY, Taeihagh A, Robinson S, Melendez-Torres GJ (In Press). A realist synthesis to develop an explanatory model of how policy instruments impact child and maternal health outcomes. Social Science & Medicine
Society for Social Medicine and Population Health ECR Subcommittee, Hayes CB (In Press). Early career researchers’ thoughts on academic careers: updated evidence from the Society for Social Medicine and Population Health. Journal of Epidemiology and Community Health
Trigg LA, Barnish MS, Hayward S, Shaw N, Crathorne L, Groves B, Spoors J, Strong T, Melendez-Torres GJ, Farmer C, et al (2024). An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund. Pharmacoecon Open, 8(2), 303-311. Abstract. Author URL.
Farmer C, Barnish MS, Trigg LA, Hayward S, Shaw N, Crathorne L, Strong T, Groves B, Spoors J, Melendez Torres GJ, et al (2023). An evaluation of managed access agreements in England based on stakeholder experience. International Journal of Technology Assessment in Health Care, 39(1). Abstract.
Farmer C, O’Toole B, Barnish MS, Trigg LA, Hayward S, Crathorne L, Kasten Z, Spoors J, Melendez-Torres GJ (2023). Early access schemes for innovative health technologies: the views of international stakeholders. International Journal of Technology Assessment in Health Care, 39(1). Abstract.
Jones ML, Barnish MS, Hughes RR, Murray AK, Mansour O, Loni T, Vickery HM, Evans ML, Green L, Verdezoto N, et al (2023). Exploring the potential of using simulation games for engaging with sheep farmers about lameness recognition. Front Vet Sci, 10 Abstract. Author URL.
Barnish MS, Nelson-Horne RV (2023). Group-based active artistic interventions for adults with primary anxiety and depression: a systematic review. BMJ Open, 13(6), e069310-e069310. Abstract.
Ghiasvand H, Barnish MS, Moradi T, Nikram E, Naghdi S (2022). Making orphan drugs and services available and accessible for people who live with rare diseases: what has been done? a systematic scoping review. EXPERT OPINION ON ORPHAN DRUGS, 10(1), 55-64. Author URL.
Barnish MS, Tan SY, Taeihagh A, Tørnes M, Nelson-Horne RVH, Melendez-Torres GJ (2021). Linking political exposures to child and maternal health outcomes: a realist review. BMC Public Health, 21(1). Abstract.
Barnish MS, Barran SM (2020). A systematic review of active group-based dance, singing, music therapy and theatrical interventions for quality of life, functional communication, speech, motor function and cognitive status in people with Parkinson’s disease. BMC Neurology, 20(1). Abstract.
Barnish M, Daley DJ, Deane KHO, Clark AB, Gray RJ, Horton SMC, Butterfint ZR, Myint PK (2019). Cognitive profile and determinants of poor cognition in people without dementia in Parkinson's disease. Medical Journal of the Islamic Republic of Iran, 33
Whibley D, AlKandari N, Kristensen K, Barnish M, Rzewuska M, Druce KL, Tang NKY (2019). Sleep and Pain: a Systematic Review of Studies of Mediation. Clin J Pain, 35(6), 544-558. Abstract. Author URL.
Varley-Campbell J, Mujica Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill TM, Kay T, et al (2019). Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation. Health Technology Assessment, 23(13).
Barnish M, Tørnes M, Nelson-Horne B (2018). How much evidence is there that political factors are related to population health outcomes? an internationally comparative systematic review. BMJ Open, 8, e020886-e020886.
Barnish M (2018). The inclusion of retracted studies in systematic reviews: a response to Gray et al. (2018). International Journal of Nursing Studies, 80, 90-91.
Barnish MS, Tagiyeva N, Devereux G, Aucott L, Turner S (2017). Changes in the relationship between asthma and associated risk factors over fifty years. Pediatric Allergy and Immunology, 28(2), 162-169. Abstract.
Macfarlane GJ, Barnish MS, Pathan E, Martin KR, Haywood KL, Siebert S, Packham J, Atzeni F, Jones GT (2017). Co‐Occurrence and Characteristics of Patients with Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia. Arthritis & Rheumatology, 69(11), 2144-2150. Abstract.
Macfarlane GJ, Barnish MS, Jones GT (2017). Persons with chronic widespread pain experience excess mortality: longitudinal results from UK Biobank and meta-analysis. Ann Rheum Dis, 76(11), 1815-1822. Abstract. Author URL.
Barnish MS, Horton SMC, Butterfint ZR, Clark AB, Atkinson RA, Deane KHO (2017). Speech and communication in Parkinson’s disease: a cross-sectional exploratory study in the UK. BMJ Open, 7(5), e014642-e014642.
Barnish M, Morgan HM, Barnish J (2017). The 2016 HIGh Heels: Health effects and psychosexual BenefITS (HIGH HABITS) study: systematic review of reviews and additional primary studies. BMC Public Health, 18(1).
Reynolds SE, Richardson SV, Barnish M, Reid I, Ross R, Campbell R, Horne B (2017). The Politics of Women’s Fashion in the Cultural West: a Perspective. Art and Design Review, 5, 252-257.
Barnish MS, Turner S (2017). The value of pragmatic and observational studies in health care and public health. Pragmat Obs Res, 8, 49-55. Abstract. Author URL.
Barnish MS, Barnish J (2016). High-heeled shoes and musculoskeletal injuries: a narrative systematic review. BMJ Open, 6(1). Abstract. Author URL.
Barnish J, Atkinson RA, Barran SM, Barnish MS (2016). Potential Benefit of Singing for People with Parkinson's Disease: a Systematic Review. JOURNAL OF PARKINSONS DISEASE, 6(3), 473-484. Author URL.
Barnish MS, Whibley D, Horton SMC, Butterfint ZR, Deane KHO (2016). Roles of Cognitive Status and Intelligibility in Everyday Communication in People with Parkinson's Disease: a Systematic Review. JOURNAL OF PARKINSONS DISEASE, 6(3), 453-462. Author URL.
Barnish MS, Tagiyeva N, Devereux G, Aucott L, Turner S (2015). Diverging prevalences and different risk factors for childhood asthma and eczema: a cross-sectional study. BMJ Open, 5(6). Abstract. Author URL.
Macfarlane GJ, Barnish MS, Jones EA, Kay L, Keat A, Meldrum KT, Pathan E, Sturrock RD, Zabke C, McNamee P, et al (2015). The British Society for Rheumatology Biologics Registers in Ankylosing Spondylitis (BSRBR-AS) study: Protocol for a prospective cohort study of the long-term safety and quality of life outcomes of biologic treatment. BMC Musculoskelet Disord, 16 Abstract. Author URL.
Barnish M (2014). A quantitative content analysis of person-first language use in healthcare research, healthcare practice, and by support groups for people with disabilities. Open Journal of Modern Linguistics, 4, 505-511.
Reports
O'Toole B, Muthukumar M, Robinson S, Lowe J, Melendez-Torres GJ, Barnish M (2023). Axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma.
Barnish M, Muthukumar M, Lovell A, Abdelsabour A, McBride P, Perks J, Farmer C, Wilson E, Dawes H, Melendez-Torres GJ, et al (2023). Digital pulmonary rehabilitation technologies for adults with chronic obstructive pulmonary disease [GID-HTE10019].
Barnish M, O'Toole B, Nikram E, Matthews J, Robinson S, Abdelsabour A, Knapper S, Wilson E (2023). Ivosidenib with azacitidine for untreated IDH1-positive acute myeloid leukaemia: a Single Technology Appraisal.
Lee D, Muthukumar M, Lovell A, Farmer C, Burns D, Matthews J, Coelho H, O'Toole B, Trigg L, Snowsill T, et al (2023). Treatments for renal cell carcinoma [ID 6186]: a pathways pilot appraisal.
Barnish M, Lovell A, Robinson S, Nikram E, Farmer C, Wilson E (2023). Virtual reality for treating agoraphobia and agoraphobic avoidance: early value assessment [MT725].
Barnish M, Sullivan W, Matthews J, Day C, Robinson S, Long L, Phillips Z, Dorey N (2022). Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer.
Barnish M, Lee D, Robinson S, Sadik A, Brand A, Trigg L, Wilson E (2022). Digitally enabled therapies for adults with depression [MTG588].
O'Toole B, Barnish M, Wilson E, Matthews J, Coelho H, Shaw N, et al. (2022). Pembrolizumab with lenvatinib for previously treated advanced, metastatic or recurrent endometrial cancer. NICE.
Barnish M, Robinson S, Trigg L, Wilson E (2022). Review report of MTG42, UrgoStart for treating diabetic foot ulcers and leg ulcers.
Barnish M, Naik J, Sullivan W, Brand A, Hook E, Matthews J, Edmonson-Jones M, et al (2022). Risankizumab for previously treated moderately to severely active Crohn's disease.
Farmer C, O'Toole B, Barnish M, Trigg L, Hayward S, Crathorne L, Melendez-Torres GJ (2021). A Strategic Approach to Early Access Schemes:. Results.
Farmer C, Barnish M, Trigg L, Shaw N, Hayward S, Crathorne L, Melendez-Torres GJ (2021). Findings from a quantitative and qualitative evaluation of managed access agreements in the UK.
Barnish M, Brian O, Packman D, Muthukumar M, Matthews J, Shaw N, Rudin CE, Crathrone L, Melendez-Torres G (2021). Pembrolizumab for treating relapsed or. refractory classical Hodgkin’s lymphoma after. 1 or more multi-agent chemotherapy. regimens:. a Single Technology Appraisal. NICE.
Bullement A, Barnish M, Slater R, Shaw N, Matthews J, Crathorne L, Long L, Melendez-Torres G (2021). Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced oesophageal and gastro-oesophageal junction cancer.
Brand A, Muthukumar M, Barnish M, O'Toole B, Trigg L, Robinson S, Tan T, O'Rahilly S, Melendez-Torres GJ, Crathorne L, et al (2021). Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764].
Barnish M, Cummins E, Coelho H, Johnston R, Packman D, Shaw N, Haigh R, Crathorne L, Melendez-Torres GJ (2020). Upadacitinib for treating moderate to severe rheumatoid arthritis [ID1400]: a Single Technology Appraisal. NICE.
Tikhonova I, Long L, Ocean N, Barnish M, Robinson S, Nikram E, Bello S, Dodman S, Halpin D, Hoyle M, et al (2018). Benralizumab for treating severe asthma: a Single Technology Appraisal.
Varley-Campbell J, Mujica-Mota R, Coelho H, Ocean N, Barnish M, Packman D, Dodman S, Cooper C, Snowsill T, Kay T, et al (2018). Biomarker tests to help diagnose preterm labour in women with intact membranes. NICE.
Griffin E, Barnish M, Packman D, Coelho H, Matthews J, Dodman S, Robinson S, Dangoor A, Dorey N, Hoyle M, et al (2018). Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib: a Single Technology Appraisal. NICE.
Griffin E, Farmer C, Packman D, Nikram E, Matthews J, Barnish M, Briscoe S, Dorey N, Dangoor A, Mujica Mota R, et al (2018). Pembrolizumab with pemetrexed and platinum chemotherapy for untreated metastatic non-squamous non-small-cell lung cancer [ID1173]: a Single Technology Appraisal. NICE.
Barnish M, Morgan HM (2017). Are high heels bad for your health? Two experts review the evidence. The Conversation.
Barnish M (2013). Relationships between cognitive status, speech impairment and communicative participation in Parkinson’s disease. University of East Anglia.
External Engagement and Impact
Committee/panel activities
- 2022, Member of Organising Committee, Society for Social Medicine and Population Health Annual Scientific Meeting, Exeter
- 2019, Newsletter Editor, Society for Social Medicine and Population Health
- 2018, Chair and Welfare Officer, Early Career Researchers Subcommittee, Society for Social Medicine and Population Health
- 2017-2018, Committee Member, Society for Social Medicine and Population Health
Invited lectures
- The Society for Social Medicine and Population Health, Beyond Exeter: Networks for Early Career and Postgraduate Researchers, Exeter (UK), May 2019
- An introduction to the Society for Social Medicine and Population Health Early Career Researchers Welfare Framework, Early Career Researchers Workshop, Society for Social Medicine Annual Scientific Meeting, Manchester (UK), September 2018
- Health policy and the politics of being an Early Career Researcher, Early Career Researchers Workshop, Society for Social Medicine Annual Scientific Meeting, Manchester (UK), September 2017
Media Coverage
- My work has featured widely in popular and health-related media and contributed to increased public awareness and developments in social policy and clinical practice
- I have also published clinical feature articles in the Royal College of Speech and Language Therapists Bulletin on my work about functional communication in Parkinson’s disease
Significant Impact
- I work on a health technology assessment stream commissioned by NICE, which directly informs NICE appraisals and clinical guidance for medicine and diagnostics reimbursement in England and Wales
